Penny Stocks: Stocks likely to be in focus tomorrow!

Penny Stocks: Stocks likely to be in focus tomorrow!

Armaan Madhani
/ Categories: Trending, Penny Stocks

Mid-cap and Small-cap stocks bucked the trend and saw buying interest.

On Thursday, Indian equity markets Indian equity markets ended on a sombre note owing to weak global cues. Nifty 50 closed at 18,052.70, down by 0.17 per cent. Mid-Cap and Small-Cap stocks bucked the trend and saw buying interest.

The following penny stocks are likely to be in focus on Friday, November 4, 2022:     

Ajooni Biotech - A strong price volume breakout was witnessed in this counter today. The stock rallied more than 14 per cent to record an intra-day high of Rs 7.90 per share on NSE. The company is engaged in the manufacturing and sale of animal feed and feed supplements. 

GTL Infrastructure – The scrip locked at an upper price band of Rs 1.35 per share on NSE, up by 8 per cent. Incorporated in 2004, the company is in the business of passive infrastructure sharing which is based on building, owning, operating and maintaining passive telecom infrastructure sites.

Andhra Cements – Only buyers were seen in the scrip today. The stock got locked at a 5 per cent upper circuit, recording an intra-day high of Rs 6.60 per share. The company is in the business of cement production and is a part of the Jaypee Group. It has two manufacturing plants situated in Andhra Pradesh. The company has been undergoing insolvency proceedings, while Sagar Cements and Dalmia Cement (India) seem to be the front-runners for acquiring the company. The scrip has gained 14.78 per cent over the last five trading sessions.  

Following is the list of volume breakout penny stocks that witnessed heavy buying in today’s session:   

Stock Name  LTP  Gain (%)  Volume Change (Times)
Setubandhan Infrastructure 2.2 10 8
Innocorp 4.99 9.91 2
Lypsa Gems & Jewellery 7.3 9.77 2
Smiths & Founders (India) 5.39 9.33 4
Previous Article BSE 500: These NBFC stocks were among the top gainers in todays session
Next Article Multibagger Update: This micro-cap pharma stock hit an all-time high!
Rate this article:
4.0

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR